Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Trial of V212 in Adults With Solid Tumors or Hematologic Malignancies
KCT0000393Phase 3Recruiting
- Sponsor
- Merck & Co.
- Start
- Oct 2011
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of zoster vaccine live in herpes zoster (HZ), sponsored by Merck & Co.. Started Oct 2011; status: recruiting.
02
Drugs
zoster vaccine live
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on KCT0000393.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000393.